Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IgM Component
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IgM Component
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 4, Pages e93903
Publisher
Public Library of Science (PLoS)
Online
2014-04-05
DOI
10.1371/journal.pone.0093903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy
- (2013) Jae-Sook Ahn et al. AMERICAN JOURNAL OF HEMATOLOGY
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
- (2013) H. Horn et al. BLOOD
- MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
- (2013) L. Xu et al. BLOOD
- Diffuse large B-cell lymphoma
- (2013) Maurizio Martelli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations
- (2013) Mette Ø. Pedersen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
- (2013) U. Randen et al. HAEMATOLOGICA
- MYD88 expression and L265P mutation in diffuse large B-cell lymphoma
- (2013) Jung-Woo Choi et al. HUMAN PATHOLOGY
- High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
- (2013) W Kraan et al. Blood Cancer Journal
- Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Tina Marie Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) C Visco et al. LEUKEMIA
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
- (2012) J. G. Lohr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Prognostic significance ofMYC,BCL2, andBCL6rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab
- (2011) Nalan Akyurek et al. CANCER
- Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma
- (2011) Matthew J. Maurer et al. JOURNAL OF CLINICAL ONCOLOGY
- IgM Expression on Paraffin Sections Distinguishes Primary Cutaneous Large B-cell Lymphoma, Leg Type From Primary Cutaneous Follicle Center Lymphoma
- (2010) Lianne Koens et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
- (2010) G. Ott et al. BLOOD
- Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas
- (2010) Roland Schroers et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
- (2010) S. Montes-Moreno et al. HAEMATOLOGICA
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Monoclonal gammopathy as a marker of primary cerebral lymphoma
- (2009) R. Ria et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study
- (2009) U. Vitolo et al. HAEMATOLOGICA
- Epstein-Barr virus–positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations
- (2009) Sylvia Hoeller et al. HUMAN PATHOLOGY
- Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study
- (2009) Christiane Copie-Bergman et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma
- (2008) Kai Fu et al. JOURNAL OF CLINICAL ONCOLOGY
- Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma
- (2008) Maria Christina Cox et al. LEUKEMIA & LYMPHOMA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started